Results 41 to 50 of about 29,499 (226)

High-throughput validation of ceRNA regulatory networks

open access: yesBMC Genomics, 2017
Background: MicroRNAs (miRNAs) play multiple roles in tumor biology [1]. Interestingly, reports from multiple groups suggest that miRNA targets may be coupled through competitive stoichiometric sequestration [2]. Specifically, computational models predicted [3, 4] and experimental assays confirmed [5, 6] that miRNA activity is dependent on miRNA target
Hua-Sheng Chiu   +7 more
openaire   +4 more sources

Construction and Analysis of the lncRNA-miRNA-mRNA Network Based on Competing Endogenous RNA in Atrial Fibrillation

open access: yesFrontiers in Cardiovascular Medicine, 2022
BackgroundAccumulated studies have revealed that long non-coding RNAs (lncRNAs) play critical roles in human diseases by acting as competing endogenous RNAs (ceRNAs).
Xiangyu Ke   +8 more
doaj   +1 more source

PseudoFuN: Deriving functional potentials of pseudogenes from integrative relationships with genes and microRNAs across 32 cancers [PDF]

open access: yes, 2019
BACKGROUND: Long thought "relics" of evolution, not until recently have pseudogenes been of medical interest regarding regulation in cancer. Often, these regulatory roles are a direct by-product of their close sequence homology to protein-coding genes.
Campbell, Moray J.   +7 more
core   +1 more source

The ceRNA network of lncRNA and miRNA in lung cancer [PDF]

open access: yesGenomics & Informatics, 2020
Since lung cancer is a major causative for cancer-related deaths, the investigations for discovering biomarkers to diagnose at an early stage and to apply therapeutic strategies have been continuously conducted. Recently, long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) are being exponentially studied as promising biomarkers of lung cancer ...
Seo, Danbi   +3 more
openaire   +2 more sources

The miR-223 host non-coding transcript linc-223 induces IRF4 expression in acute myeloid leukemia by acting as a competing endogenous RNA [PDF]

open access: yes, 2016
Alterations in genetic programs required for terminal myeloid differentiation and aberrant proliferation characterize acute myeloid leukemia (AML) cells.
Bozzoni, Irene   +8 more
core   +2 more sources

Comprehensive analysis of ceRNA network of ERCC4 in colorectal cancer

open access: yesPeerJ, 2021
Objective ERCC4 is one of the most significant molecules of Nucleotide Excision Repair (NER), which has been researched due to its high expression in colorectal cancer (CRC). This study aimed to find out the ceRNA (competitive endogenous RNA) network of ERCC4 in CRC.
Huixin Hu   +5 more
openaire   +3 more sources

Systematic Identification of lncRNA-Associated ceRNA Networks in Immune Thrombocytopenia [PDF]

open access: yesComputational and Mathematical Methods in Medicine, 2020
Primary immune thrombocytopenia (ITP) is an autoimmune disease. However, the molecular mechanisms underlying ITP remained to be further investigated. In the present study, we analyzed a series of public datasets (including GSE43177 and GSE43178) and identified 468 upregulated mRNAs, 272 downregulated mRNAs, 134 upregulated lncRNAs, 23 downregulated ...
Zhenwei Fan   +6 more
openaire   +2 more sources

Identification of programmed cell death-related gene signature and associated regulatory axis in cerebral ischemia/reperfusion injury

open access: yesFrontiers in Genetics, 2022
Background: Numerous studies have suggested that programmed cell death (PCD) pathways play vital roles in cerebral ischemia/reperfusion (I/R) injury.
Jun Shu, Lu Yang, Wenshi Wei, Li Zhang
doaj   +1 more source

Construction of novel lncRNA-miRNA-mRNA ceRNA networks associated with prognosis of hepatitis C virus related hepatocellular carcinoma

open access: yesHeliyon, 2022
Background: Hepatitis C virus (HCV) infection contribute to liver fibrosis and cirrhosis, which significantly increases the risk of hepatocellular carcinoma (HCC) development.
Lishi Shao   +3 more
doaj   +1 more source

ceRNA network analysis reveals prognostic markers for glioblastoma

open access: yesOncology Letters, 2019
Glioblastoma (GBM) is a common aggressive cancer that originates in the brain, which has a poor prognosis. It is therefore crucial to understand its underlying genetic mechanisms in order to develop novel therapies. The present study aimed to identify some prognostic markers and candidate therapeutic targets for GBM.
Wang, Hao   +3 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy